However, a notable side effect was observed: MT-II-treated normal C57BL/6J mice exhibited significant weight loss, with their average weight decreasing from a baseline of 30.9 1.4 grams to 26.5 1.7 grams after the 14-day treatment course, a change not seen in vehicle-treated controls
Participants in the SGLT2i group were less likely to require admission to hospital for any reason than those in the GLP-1 RA group (RR 0.59 [95% CI 0.46, 0.76] p 0.0001)
A new study reports that of the 1 million new GLP-1 medication users identified between 2011 to 2023, there was a twofold increase in GLP-1 medication users who do not have type 2 diabetes
Hydration and Fiber: The Foundation of Digestive Comfort Drinking adequate water is the single most effective non-medication strategy for managing tirzepatide-related constipation
A su juicio, el siguiente paso debera ser validar estos datos en ensayos clnicos especficos para convertir este hallazgo accidental en un tratamiento oficial contra la adiccin y transformar la salud pblica a nivel global
Health Canada consumer warning (April 2026): Think twice before injecting peptides bought online Government of Canada